Mutations and polymorphisms in the tuberous sclerosis complex gene on chromosome 16

✍ Scribed by Kit-Sing Au; Joseph A. Rodriguez; Estanislado Rodriguez Jr.; William B. Dobyns; Mauricio R. Delgado; Hope Northrup

• Publisher: John Wiley and Sons
• Year: 1997
• Tongue: English
• Weight: 240 KB
• Volume: 9
• Category: Article
• ISSN: 1059-7794
• DOI: 10.1002/(sici)1098-1004(1997)9:1<23::aid-humu4>3.0.co;2-q

✦ Synopsis

Tuberous sclerosis complex (TSC) is an autosomal dominant disorder of benign tumor formation, hamartomata, and hamartias. TSC has been shown to be genetically heterogeneous, with one causative gene mapping to chromosome 9q (denoted TSC1) and at least one other gene on chromosome 16p (denoted TSC2). The TSC2 gene was recently cloned. We have tested 88 TSC probands with the TSC2 cDNA by Southern blotting searching for gross deletions/rearrangements/insertions. We detected two deletions and a rare intragenic polymorphic variant. This is a similar rate of mutation detection (2/88; 2.3%) to that in the original report (10/260/;3.8%). The rare polymorphic variant was initially detected in the proband of a chromosome 9 linked multiplex TSC family. The polymorphism segregated with previously tested markers on chromosome 16 independently of the disease gene, verifying that the variation was unrelated to TSC status. We have also begun searching for subtle mutations by SSCA and direct sequencing. After screening three exons, we found two intragenic polymorphic variants. Both polymorphisms are common, making them useful for linkage studies in known affected families.